Trials / Terminated
TerminatedNCT00910416
The Comparability of Bispectral Index and Neurosense During Anesthesia
The Comparability of Bispectral Index and Neurosense During Total Intravenous Anesthesia and Balanced Anesthesia
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | propofol, remifentanil, atracurium | propofol, remifentanil, atracurium dosages are adapted according to clinician's judgment |
| DRUG | propofol, remifentanil, atracurium, sevoflurane | dosages are adapted according to clinician's judgment |
| DEVICE | EEG monitoring | simultaneous monitoring with Bis and Neurosense |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-05-29
- Last updated
- 2016-09-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00910416. Inclusion in this directory is not an endorsement.